FDA Will Inspect Guidant Facilities; Design Change Guidance On Horizon
This article was originally published in The Gray Sheet
FDA is planning "a comprehensive, onsite inspection" of Guidant's manufacturing facilities following the firm's recent recalls of several implantable defibrillators and pacemakers, an agency spokesperson said
You may also be interested in...
Guidant will offer free replacements of certain ICD and CRT-D models following the failure of a small number of the devices, but the firm is not recommending substitution across the board
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.